The management of patients with head and neck cancer is complex, and treatment of squamous cell carcinoma of the head and neck (SCCHN) varies according to clinical characteristics and the expertise of the medical team. Comorbidity is frequent in SCCHN patients and can preclude aggressive therapy [1â€“4]. Moreover, SCCHN and its treatment may negatively affect basic physiological functions, senses, speech, and physical appearance [5].